Assignee
DAMIAN PHARMA AG
CH·4 granted patents·2 pending applications·8 citations·filing 2017–2024
Top patents by PatentIndex Score
6 records- 0193US11447491B2Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2020·Granted Sep 20, 2022·3 cites·28 claims
- 0291US10822332B2Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2017·Granted Nov 3, 2020·5 cites·17 claims
- 0384US2025129071A1Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2024·Application pending·0 cites
- 0480US12202827B2Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2022·Granted Jan 21, 2025·0 cites·24 claims
- 0571US2024269119A1R-fadrozole for use in the treatment of aldostonerismDAMIAN PHARMA AG·Filed 2024·Application pending·0 cites
- 0657US11992479B2R-fadrozole for use in the treatment of aldostonerismDAMIAN PHARMA AG·Filed 2019·Granted May 28, 2024·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →